Consonance Capital Management as of Dec. 31, 2013
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 27 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 10.7 | $65M | 579k | 113.08 | |
| Wuxi Pharmatech Cayman Spons Adr Shs | 7.9 | $48M | 1.3M | 38.38 | |
| Endo Pharmaceuticals | 7.4 | $45M | 671k | 67.46 | |
| Aegerion Pharmaceuticals | 6.2 | $38M | 537k | 70.96 | |
| Cardiovascular Systems | 6.1 | $38M | 1.1M | 34.29 | |
| BioScrip | 4.8 | $29M | 3.9M | 7.40 | |
| Furiex Pharmaceuticals | 4.5 | $27M | 649k | 42.01 | |
| Insys Therapeutics Com New | 4.4 | $27M | 698k | 38.71 | |
| Taro Pharmaceutical Inds SHS (TARO) | 4.3 | $26M | 264k | 98.90 | |
| Medicines Company | 4.2 | $26M | 661k | 38.62 | |
| Emergent BioSolutions (EBS) | 4.1 | $25M | 1.1M | 22.99 | |
| AMAG Pharmaceuticals | 4.1 | $25M | 1.0M | 24.28 | |
| Cadence Pharmaceuticals | 3.9 | $24M | 2.6M | 9.05 | |
| Enanta Pharmaceuticals (ENTA) | 3.8 | $23M | 851k | 27.28 | |
| Salix Pharmaceuticals | 3.8 | $23M | 258k | 89.94 | |
| Anacor Pharmaceuticals In | 3.8 | $23M | 1.4M | 16.78 | |
| Orthofix International Nv Com Stk | 3.5 | $21M | 931k | 22.82 | |
| Osiris Therapeutics | 2.6 | $16M | 976k | 16.08 | |
| Hyperion Therapeutics | 2.4 | $15M | 734k | 20.22 | |
| Galena Biopharma | 2.4 | $15M | 3.0M | 4.96 | |
| Sucampo Pharmaceuticals Cl A | 1.4 | $8.7M | 925k | 9.40 | |
| Clovis Oncology | 1.4 | $8.6M | 142k | 60.27 | |
| Chindex International | 1.0 | $6.3M | 363k | 17.43 | |
| Masimo Corporation (MASI) | 0.7 | $4.0M | 137k | 29.23 | |
| Liposcience | 0.3 | $1.9M | 443k | 4.25 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $1.3M | 104k | 12.41 | |
| Ariad Pharmaceuticals | 0.0 | $84k | 12k | 6.85 |
